NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 7 நாட்களுக்கு முன்இன்று 15 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Paramount Cosmetics Q2 FY27 PAT Rises to Rs 27.15 Lakh Despite 68% Drop in Revenue to Rs 2.78 Cr
Paramount Cosmetics reported its Q2 FY27 (quarter ended September 30, 2026) financial results, showing revenue from operations down 68% YoY to Rs 277.79 lakh (Rs 2.78 crore) compared to Rs 869.23 lakh in Q2 FY26. Net profit for the quarter rose to Rs 27.15 lakh from Rs 12.65 lakh in the year-ago period, aided by other income of Rs 78.40 lakh. Operating cash flow for H1 FY27 turned negative at -Rs 399.33 lakh, compared to +Rs 1,076.67 lakh in FY26. A notable disclosure confirms the sale of its factory assets to related party Paramount Kumkum Pvt Ltd for Rs 392.75 lakh, for which registration formalities remain ongoing.
உச்சம் நம்பிக்கை
என்ன மாறியதுParamount Cosmetics approved and declared its standalone unaudited Q2 and H1 FY27 financial results along with an update on pending asset sale registrations.
ஏன் இது முக்கியம்Top-line contraction is severe (down 68% YoY), and reported profitability is primarily cushioned by other income (Rs 78.4 lakh), while the core business operating cash flow has turned negative.
Q2 FY27 Revenue from Operations: ரூ. 277.79 லட்சம்Q2 FY27 Net Profit (PAT): ரூ. 27.15 லட்சம்Q2 FY27 Other Income: ரூ. 78.40 லட்சம்Factory Sale Consideration to Related Party: ரூ. 392.75 லட்சம்Factory Sale vs TTM Revenue: ~19.6%
📅 குறுகிய காலம்Muted to cautious sentiment given the sharp drop in revenue from operations despite higher reported net profit.
📈 நீண்ட காலம்Disposal of manufacturing facilities to a related party indicates a structural shift toward asset-light or outsourced operations, requiring proof of revenue sustainability.
⚠ அபாய எச்சரிக்கைகள்
Sharp top-line drop (-68% YoY)
Substantial related-party asset sale (Rs 3.93 cr) with ongoing property registration
Negative operating cash flows of Rs 3.99 cr in H1 FY27
👀 கவனிக்க வேண்டியவை
Monitor whether core operating revenues stabilize in upcoming quarters and track completion of property registration for the Rs 3.93 crore related-party factory sale.
Paramount Cosmetics Board Approves Up to ₹72 Cr Rights Issue
Paramount Cosmetics India Ltd's board has approved raising funds via a Rights Issue of equity shares (face value ₹10 each) for an aggregate amount not exceeding ₹72 crore. This proposed fundraise is massive compared to the company's existing scale, representing approximately 10.3x its current market capitalization of ₹7 crore and over 3.5x its TTM revenue of ₹20 crore. The detailed terms, issue price, ratio, and record date will be determined subsequently by the newly authorized 'Right Issue Committee'.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board of Directors approved raising up to ₹72 crore through the issuance of equity shares on a rights basis.
ஏன் இது முக்கியம்The fundraise is exceptionally large relative to the company's ₹7 crore market capitalization and ₹20 crore net worth, implying potentially massive equity dilution or major business transformation depending on subscription and use of proceeds.
Approved fundraise size: up to Rs. 72 croreஒரு பங்கின் முக மதிப்பு: 10/- eachFundraise vs Market Cap: ~1028%Fundraise vs TTM Revenue: ~360%
📅 குறுகிய காலம்Investors will watch for the announcement of the Rights Issue price, issue ratio, and record date to gauge shareholder dilution and pricing discount.
📈 நீண்ட காலம்If successfully executed, an influx of up to ₹72 crore could fundamentally alter the balance sheet of this microcap firm, though capital allocation efficiency remains critical.
⚠ அபாய எச்சரிக்கைகள்
Severe dilution risk given fundraise size is over 10x current market capitalization
Execution and subscription risk regarding full take-up of the ₹72 crore issue
No specific end-use of proceeds disclosed yet
👀 கவனிக்க வேண்டியவை
Track subsequent filings for the Rights Issue price, entitlement ratio, record date, and clarity on the specific end-use/deployment plans for the ₹72 crore capital.
Paramount Cosmetics Board to Meet on October 12, 2026 to Consider Fundraise Options
Paramount Cosmetics India Ltd has scheduled a Board of Directors meeting on October 12, 2026, to consider and evaluate various fundraising proposals. The options under consideration include Qualified Institutions Placement (QIP), private placement, preferential issue, rights issue, or other permissible modes. Given the company's micro-cap size of Rs 7 crore market capitalization and TTM revenue of Rs 20 crore, any substantial fundraise could lead to significant equity dilution or balance sheet changes. The proposal remains subject to Board, Audit Committee, shareholder, and regulatory approvals.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company announced a formal board meeting to consider multiple potential capital-raising avenues.
ஏன் இது முக்கியம்For a company with a market capitalization of just Rs 7 crore and annual revenue around Rs 21 crore, raising capital could significantly alter the equity base, leverage, or growth trajectory depending on the issue quantum.
Board meeting date: அக்டோபர் 12, 2026Meeting time: 03:00 P.M. (IST)Company Market Cap: Rs 7 கோடிTTM வருவாய்: Rs 20 கோடி
📅 குறுகிய காலம்Trading sentiment may focus on the outcome of the October 12 meeting regarding dilution size and instrument type.
📈 நீண்ட காலம்If equity capital is raised and successfully deployed into expanding the personal care business, it could help scale revenue beyond the current Rs 20-22 crore plateau.
⚠ அபாய எச்சரிக்கைகள்
High equity dilution risk for existing minority shareholders given the tiny Rs 7 crore market cap
Uncertainty around the fundraising quantum, investor demand, and execution mode
👀 கவனிக்க வேண்டியவை
Track the outcome of the October 12, 2026 board meeting for the specific fundraising mechanism, issue size, pricing, and potential equity dilution details.
Paramount Cosmetics Proposes 680% Hike in Authorized Capital to Rs 39 Cr Ahead of Oct 29 EGM
Paramount Cosmetics India Ltd has issued an Extraordinary General Meeting (EGM) notice scheduled for October 29, 2026. The company is seeking shareholder approval to increase its Authorized Share Capital from Rs 5.00 crore to Rs 39.00 crore (divided into 3.90 crore equity shares of Rs 10 each). This represents a nearly eight-fold expansion in authorized headroom relative to its current market cap of Rs 7 crore and net worth of Rs 20 crore. Remote e-voting is set between October 26 and October 28, 2026, with the cut-off date on October 23, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company issued an EGM notice to approve increasing its authorized share capital from Rs 5 crore to Rs 39 crore.
ஏன் இது முக்கியம்A sharp rise in authorized share capital typically precedes a sizeable equity fundraise, preferential issue, or corporate restructuring, which could cause substantial equity dilution given its current Rs 7 crore market cap.
Current Authorized Capital: Rs. 5,00,00,000/-Proposed Authorized Capital: Rs. 39,00,00,000/-Proposed Capital vs Market Cap: ~557%E-voting cut-off date: 23rd அக்டோபர் 2026EGM date: 29th அக்டோபர், 2026
📅 குறுகிய காலம்E-voting runs from October 26 to October 28, followed by voting results after the October 29 EGM.
📈 நீண்ட காலம்If followed by an actual capital issuance of this scale, it will materially alter the company's capital structure and shareholding base.
⚠ அபாய எச்சரிக்கைகள்
Potential high equity dilution risk if large capital is subsequently issued
Purpose of capital increase not detailed in the explanatory statement
👀 கவனிக்க வேண்டியவை
Track subsequent disclosures on why this authorized capital is being expanded, specifically looking out for potential preferential allotments, rights issues, or acquisitions that could dilute or re-rate equity.
Paramount Cosmetics Proposes Hike in Authorized Capital from Rs 5 Cr to Rs 39 Cr
Paramount Cosmetics India Ltd's Board has approved an increase in its authorized share capital from Rs 5.00 crore to Rs 39.00 crore, divided into 3.90 crore equity shares of Rs 10 each. This nearly eightfold increase in authorized capital requires shareholder approval at an upcoming Extra Ordinary General Meeting (EGM). For a company with a current market cap of Rs 7 crore and annual revenue of ~Rs 20-21 crore, this headroom creation strongly indicates a potential upcoming equity fundraise, preferential issue, or corporate restructuring. The company has not yet detailed specific capital deployment or fundraise instruments.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board approved an increase in authorized share capital from Rs 5 crore to Rs 39 crore, pending shareholder approval at an EGM.
ஏன் இது முக்கியம்A substantial jump in authorized equity headroom suggests preparations for a major fundraise, conversion, or equity issuance relative to the company's Rs 7 crore market cap.
Existing Authorized Capital: Rs. 5,00,00,000/-Proposed Authorized Capital: Rs. 39,00,00,000/-Existing Number of Shares: 50,00,000Proposed Number of Shares: 3,90,00,000Face Value per Share: Rs. 10/-
📅 குறுகிய காலம்Traders will watch for details of an upcoming EGM notice and potential issuance of warrants or preferential shares.
📈 நீண்ட காலம்If accompanied by growth capital or debt retirement, it could alter the capital structure, though potential equity dilution poses a key consideration.
⚠ அபாய எச்சரிக்கைகள்
Significant potential equity dilution if newly authorized shares are fully issued
Lack of stated use of proceeds or fundraise details in the current filing
👀 கவனிக்க வேண்டியவை
Watch for the EGM notice and subsequent board filings detailing the exact mode and purpose of any planned capital raise, preferential issue, or restructuring.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Paramount Cosmetics to Increase Authorized Capital Nearly Eightfold to Rs 39 Cr
Paramount Cosmetics India Ltd announced that its Board of Directors has approved a substantial increase in authorized share capital from Rs 5.00 crore to Rs 39.00 crore, divided into 3.90 crore equity shares of Rs 10 each. The proposed change entails an alteration to the company's Memorandum of Association and is subject to shareholder approval. The company will hold an Extra Ordinary General Meeting on October 29, 2026, via video conferencing to seek shareholder consent. Such a major headroom expansion—nearly 5.5x the company's current market cap of Rs 7 crore—typically signals preparation for a future equity fundraise, preferential allotment, or restructuring.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard approved raising authorized equity capital from Rs 5 crore to Rs 39 crore, pending shareholder approval at the October 29, 2026 EGM.
ஏன் இது முக்கியம்A sharp rise in authorized capital creates headroom for significant equity issuance or corporate restructuring relative to its small current equity base and market cap of Rs 7 crore.
Existing Authorized Capital: Rs. 5,00,00,000/-Proposed Authorized Capital: Rs. 39,00,00,000/-Proposed Capital vs Market Cap: ~557%EGM Date: அக்டோபர் 29, 2026
📅 குறுகிய காலம்Market participants will await the detailed EGM notice and explanatory statement to see if an immediate capital raise or dilution is planned.
📈 நீண்ட காலம்If followed by an equity fundraise or strategic infusion, it could meaningfully alter the capital structure of this microcap business.
⚠ அபாய எச்சரிக்கைகள்
Potential large equity dilution risk if the newly created share capital headroom is fully utilized
Uncertainty regarding the specific end-use or structure of the potential fundraise
👀 கவனிக்க வேண்டியவை
Track the upcoming EGM notice and subsequent board announcements to identify the specific purpose of the share capital expansion (such as rights issue, preferential issue, or conversion).
Paramount Cosmetics Q1 PAT at ₹0.12 Cr; Proposes ₹50 Cr Annual Related Party Transaction
Paramount Cosmetics reported a net profit of ₹0.12 Cr for Q1 FY27, a recovery from a loss of ₹0.06 Cr in the year-ago period, despite a 28% decline in revenue to ₹3.36 Cr. The board has proposed a massive material related party transaction (RPT) with Paramount Kum Kum Pvt Ltd for up to ₹50 Cr annually starting FY 2027-28. This proposed RPT is approximately 2.38x the company's current TTM revenue of ₹21 Cr. Additionally, the company executed a deed of conveyance for a property sale in Valsad to the same related party.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company returned to profitability in Q1 FY27 and has initiated a massive long-term supply/distribution agreement with a promoter-linked entity starting in 2027.
ஏன் இது முக்கியம்The proposed ₹50 Cr annual transaction suggests a potential major shift in the company's business model or a consolidation of promoter-group operations into the listed entity, which could significantly alter its financial profile.
Q1 வருவாய்: ₹3.36 கோடிQ1 Net Profit: ₹0.12 கோடிProposed Annual RPT: ₹50 கோடிRPT vs TTM Revenue: 238%சந்தை மதிப்பு: ₹19 கோடி
📅 குறுகிய காலம்The return to profitability is a positive sign, but the stock may remain volatile as investors digest the implications of the large-scale related party transactions and property sale.
📈 நீண்ட காலம்If the ₹50 Cr annual transaction materializes as planned in FY28, it could lead to a substantial re-rating of the company's revenue base, provided margins are protected in the related-party dealings.
⚠ அபாய எச்சரிக்கைகள்
Significant related-party transaction (2.4x current revenue)
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the upcoming 41st AGM for details on the property sale valuation and the justification for the ₹50 Cr annual related party transaction, which is significantly larger than the company's current scale.
Paramount Cosmetics Completes Sale of Valsad Property to Related Party
Paramount Cosmetics India Ltd has finalized the sale of its property located at Umarsadi, Pardi District, Valsad, through a Deed of Conveyance dated August 6, 2026. The transaction was executed with Paramount Kum Kum Private Limited, a related party, following shareholder approval obtained in February 2026. While the transaction value was not disclosed in this filing, the company's small scale (Market Cap Rs 18 Cr, TTM Revenue Rs 21 Cr) makes any asset disposal potentially material to its balance sheet. All formalities were completed by August 7, 2026, and noted by the Board on August 12, 2026.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுThe company has officially transferred ownership of its property in Valsad to a related party, completing a process initiated earlier in the year.
ஏன் இது முக்கியம்For a micro-cap company with a net worth of Rs 20 Cr, the sale of physical assets is a significant event that could improve liquidity or signal a shift in operational focus, though the lack of disclosed value prevents a full impact assessment.
Deed of Conveyance Date: 06.08.2026Formalities Completion Date: 07.08.2026EGM Approval Date: 13.02.2026Transaction Value: வெளியிடப்படவில்லைசந்தை மதிப்பு: Rs 18 கோடி
📅 குறுகிய காலம்The stock may experience volatility as the market processes the asset sale; however, the lack of financial specifics in the announcement may lead to a neutral reaction until the value is known.
📈 நீண்ட காலம்Asset monetization can be positive for liquidity, but as a related-party transaction, investors must ensure the sale was conducted at fair market value to protect minority interests.
⚠ அபாய எச்சரிக்கைகள்
Related-party transaction
Transaction value not disclosed
Micro-cap liquidity risk
👀 கவனிக்க வேண்டியவை
Investors should monitor the next quarterly financial statement (September 2026) to identify the transaction value and assess how the proceeds are utilized, specifically if they are used to reduce debt or fund operations.
Paramount Cosmetics Sells Shoolagiri Factory; Possession Handed Over to Buyer
Paramount Cosmetics India Ltd has entered into a sale agreement for its factory land and building located at Shoolagiri and has handed over possession to the buyer. This transaction follows shareholder approval obtained during an Extraordinary General Meeting (EGM) on February 13, 2026. While the company has received an advance, the specific sale consideration was not disclosed in this filing. The buyer is currently in the process of completing registration and transfer formalities.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுThe company has moved from a proposal to sell its Shoolagiri factory to executing a sale agreement and handing over physical possession of the property.
ஏன் இது முக்கியம்For a micro-cap company with TTM revenue of Rs 21 Cr, the sale of a manufacturing facility is a significant event that could provide a liquidity boost or indicate a shift toward an asset-light business model.
📅 குறுகிய காலம்The stock may see volatile interest as investors speculate on the cash inflow from the sale, though the lack of a specific transaction value limits immediate fundamental re-rating.
📈 நீண்ட காலம்The long-term impact depends on whether the proceeds are used to deleverage (Debt is currently Rs 2 Cr) or reinvested into higher-margin personal care segments.
Lack of transparency regarding the final sale price in the announcement
Potential impact on manufacturing capacity
👀 கவனிக்க வேண்டியவை
Investors should monitor the next quarterly financial results to identify the exact sale consideration and any 'Exceptional Item' gains, which will clarify the impact on the company's Rs 20 Cr net worth.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
